ATE495448T1 - Verfahren zur bewertung einer fettleibigkeit kontrollierenden substanz - Google Patents

Verfahren zur bewertung einer fettleibigkeit kontrollierenden substanz

Info

Publication number
ATE495448T1
ATE495448T1 AT07831767T AT07831767T ATE495448T1 AT E495448 T1 ATE495448 T1 AT E495448T1 AT 07831767 T AT07831767 T AT 07831767T AT 07831767 T AT07831767 T AT 07831767T AT E495448 T1 ATE495448 T1 AT E495448T1
Authority
AT
Austria
Prior art keywords
substance
obesity
controling
evaluation
evaluating
Prior art date
Application number
AT07831767T
Other languages
English (en)
Inventor
Akira Shimotoyodome
Junko Suzuki
Nanami Takeno
Daisuke Fukuoka
Tomohito Mizuno
Shinichi Meguro
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Application granted granted Critical
Publication of ATE495448T1 publication Critical patent/ATE495448T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
AT07831767T 2006-12-06 2007-11-07 Verfahren zur bewertung einer fettleibigkeit kontrollierenden substanz ATE495448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006329637A JP4814774B2 (ja) 2006-12-06 2006-12-06 肥満調節剤の評価方法
PCT/JP2007/072037 WO2008069004A1 (en) 2006-12-06 2007-11-07 Method for evaluating obesity controller

Publications (1)

Publication Number Publication Date
ATE495448T1 true ATE495448T1 (de) 2011-01-15

Family

ID=38984293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07831767T ATE495448T1 (de) 2006-12-06 2007-11-07 Verfahren zur bewertung einer fettleibigkeit kontrollierenden substanz

Country Status (9)

Country Link
US (1) US20100022014A1 (de)
EP (1) EP2087361B1 (de)
JP (1) JP4814774B2 (de)
CN (1) CN101548189B (de)
AT (1) ATE495448T1 (de)
AU (1) AU2007330220B2 (de)
CA (1) CA2670879C (de)
DE (1) DE602007011968D1 (de)
WO (1) WO2008069004A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120128770A1 (en) * 2009-06-24 2012-05-24 Kobenhavns Universitet Treatment of insulin resistance and obesity by stimulating glp-1 release
JP2011037843A (ja) 2009-07-16 2011-02-24 Kao Corp 食後血中インスリン濃度上昇抑制剤
WO2012096108A1 (ja) 2011-01-12 2012-07-19 花王株式会社 血中ｇｉｐ濃度上昇抑制剤、血中インスリン濃度上昇抑制剤、食後血中トリグリセリド濃度低減剤、及び血糖濃度上昇抑制剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702457D0 (sv) 1997-06-26 1997-06-26 Pharmacia & Upjohn Ab Screening
US6001578A (en) * 1997-06-26 1999-12-14 Pharmacia & Upjohn Ab Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity
FR2816633B1 (fr) * 2000-11-10 2003-02-07 Lipha Methode de criblage d'agents susceptibles de traiter l'obesite
CN1131433C (zh) * 2001-09-07 2003-12-17 上海华谊生物技术有限公司 促胰岛素分泌肽生物活性测定方法
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
CA2534309A1 (en) * 2003-07-31 2005-02-10 Banyu Pharmaceutical Co., Ltd. Method of evaluating compound efficacious in treating obesity by using slc25a10
EP1656838A4 (de) * 2003-08-21 2007-10-24 Abilit Corp Nahrungsmittel zum testen von krankheiten, die mit dem lebenswandel in zusammenhang stehen
JP2006249064A (ja) 2005-02-14 2006-09-21 Biomarker Science:Kk 糖尿病及び／又は肥満の治療・予防剤、抗糖尿病及び／又は抗肥満作用の評価方法及び評価用キット、並びに、抗糖尿病及び／又は抗肥満物質のスクリーニング方法及びスクリーニング用キット
JP2006290826A (ja) * 2005-04-13 2006-10-26 Eisai R & D Management Co Ltd スクリーニング方法
JP4878494B2 (ja) * 2006-04-24 2012-02-15 花王株式会社 食後血中インスリン上昇抑制剤

Also Published As

Publication number Publication date
CA2670879C (en) 2013-12-31
AU2007330220B2 (en) 2012-09-13
AU2007330220A1 (en) 2008-06-12
EP2087361B1 (de) 2011-01-12
DE602007011968D1 (de) 2011-02-24
WO2008069004A1 (en) 2008-06-12
CN101548189A (zh) 2009-09-30
CN101548189B (zh) 2017-03-08
JP2008145136A (ja) 2008-06-26
JP4814774B2 (ja) 2011-11-16
US20100022014A1 (en) 2010-01-28
EP2087361A1 (de) 2009-08-12
CA2670879A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
DE60303758D1 (de) System zur Überwachung des Blutzuckerwerts unter Verwendung einer implantierbaren medizinischen Vorrichtung
PL2207582T3 (pl) System i sposób monitorowania i regulowania wartości poziomu glukozy we krwi
HK1208229A1 (en) Method for control of blood kinetics of antibody
MX2009011246A (es) Dispositivo, sistema y metodo para monitorear y controlar los niveles de analito en la sangre.
EP1955240B8 (de) Verfahren zur manuellen und autonomen steuerung einer infusionspumpe
ATE499656T1 (de) Fluidverarbeitende medizinische vorrichtung und verfahren zum einrichten einer fluidverarbeitenden medizinischen vorrichtung
WO2007124448A3 (en) Method and apparatus for the management of diabetes
EA200900345A1 (ru) Замещенные ациланилиды и способы их применения
MX2011010989A (es) Control de glicosilacion de proteina y composiciones y metodos que se refieren a la misma.
DE602007007096D1 (de) Ultraschall-behandlungssystem und verfahren zur verwendung des systems
WO2006119467A3 (en) Protein activity modification
ECSP099833A (es) Anticuerpos humanizados contra el globulomero a?(20-42) y sus usos
NO20091801L (no) Peristatisk mikropumpe med utskiftbart pumpehode
NL2002411A1 (nl) System and method for tissue specific MR imaging of metabolites using spectral-spatially formed stimulated echo.
WO2009122024A8 (fr) Dispositif et procede de micro-elastographie
EP2298275A4 (de) Zusammensetzung zur topischen anwendung
ATE539676T1 (de) Vorrichtung zur verabreichung eines implantierbaren monitors
EP2031531A3 (de) Integriertes medizintechnisches Anzeigesystem
TWI348910B (en) Composition for controlling blood glucose and method thereof
BRPI0913854A2 (pt) composto, composição farmacêutica, uso do composto, e, método para o tratamento, a prevenção ou o alívio de uma doença ou um distúrbio ou uma condição de um organismo de animal vivente.
ATE495448T1 (de) Verfahren zur bewertung einer fettleibigkeit kontrollierenden substanz
RS52794B (en) PORTABLE ANALYTICAL MEASUREMENT AND CONTROL DEVICE IN BIOLOGICAL LIQUIDS
BRPI0920170A2 (pt) métodos para diminuir a quantidade de partículas ldl pequenas e densas e de níveis de triglicerídeos e ldl no sangue em um humano, e para identificar um indivíduo candidato para tratamento com um composto ou um sal, prodroga ou isômero do mesmo, composto ou um sal, prodroga ou isômero do mesmo, e método.
FR2927249B1 (fr) Dispositif de controle hemostatique d'un ecoulement sanguin
BRPI0820449B8 (pt) conjunto de implante médico para um hospedeiro

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties